NDRG2 and neoplasm: Additionally, the suppression effects of Ndrg2−/− macrophages were abolished by pretreating the macrophages with BAY-11-7082 (Fig. 7c, d), which suggested that the NF-κB pathway plays a pivotal role in inducing the Ndrg2−/− macrophage tumor-suppressor phenotype.